Sempra (NYSE: SRE) insider files to sell 23,111 shares under Rule 144

Rhea-AI Filing Summary

Sempra insider files notice to sell common stock

A holder of Sempra common stock filed a notice of proposed sale under Rule 144. The filing covers the planned sale of 23,111 shares of common stock through broker Oppenheimer & Co., Inc. on the NYSE, with an indicated aggregate market value of $2,073,287.81. The shares were acquired on February 19, 2025 through the vesting of restricted stock units granted under Sempra’s Long-Term Incentive Plan as compensation.

The notice also reports that over the prior three months, Jeffrey W. Martin sold 30,000 shares of Sempra common stock on January 2, 2026 for gross proceeds of $2,678,887.77. The company’s common shares outstanding are stated as 652,681,521, providing context for the size of these transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co., Inc. 10880 Wilshire Boulevard Los Angeles CA 90024	23111	2073287.81	652681521	01/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/19/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			23111	02/19/2025	Vesting of equity award received as compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeffrey W. Martin 488 8th Avenue San Diego CA 92101	Common Stock	01/02/2026	30000	2678887.77

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Sempra (SRE) disclose in this Form 144 filing?

The filing discloses a proposed sale under Rule 144 of 23,111 shares of Sempra common stock, to be sold through Oppenheimer & Co., Inc. on the NYSE, with an indicated aggregate market value of $2,073,287.81.

How many Sempra (SRE) shares are planned to be sold and when?

The notice covers a planned sale of 23,111 shares of Sempra common stock, with an approximate sale date of January 5, 2026, and names the NYSE as the exchange.

How were the Sempra (SRE) shares in this Form 144 acquired?

The 23,111 shares were acquired on February 19, 2025 through the vesting of restricted stock units under Sempra's Long-Term Incentive Plan, described as a vesting of an equity award received as compensation.

What recent Sempra (SRE) insider sales are reported over the past 3 months?

The filing reports that Jeffrey W. Martin, at a San Diego address, sold 30,000 shares of Sempra common stock on January 2, 2026, generating gross proceeds of $2,678,887.77.

How many Sempra (SRE) shares are outstanding according to this notice?

The document states that the number of Sempra common shares outstanding is 652,681,521, which helps put the reported and proposed sales in context.

Which broker is handling the proposed Sempra (SRE) share sale?

The proposed sale of 23,111 shares of Sempra common stock is listed as being handled by Oppenheimer & Co., Inc., located at 10880 Wilshire Boulevard, Los Angeles, CA 90024.